Results 131 to 140 of about 9,596 (243)

Treatment with Class A CpG Oligodeoxynucleotides in Cats with Naturally Occurring Feline Parvovirus Infection: A Prospective Study [PDF]

open access: gold, 2020
Filippo Ferri   +13 more
openalex   +1 more source

Synthetic Human TLR9-LRR11 Peptide Attenuates TLR9 Signaling by Binding to and thus Decreasing Internalization of CpG Oligodeoxynucleotides [PDF]

open access: gold, 2016
Xichun Pan   +8 more
openalex   +1 more source

Rationally designed Mycoplasma gallisepticum vaccine using a recombinant subunit approach

open access: yesnpj Vaccines
Mycoplasma gallisepticum (MG) is an avian respiratory pathogen causing significant global economic losses to the poultry industries. Current live-attenuated and bacterin vaccines provide some measures of protective immunity but exhibit suboptimal ...
Jeremy M. Miller   +10 more
doaj   +1 more source

Augmented immunogenicity of the HPV16 DNA vaccine via dual adjuvant approach: integration of CpG ODN into plasmid backbone and co-administration with IL-28B gene adjuvant

open access: yesVirology Journal
Therapeutic human papillomavirus (HPV) DNA vaccine is an attractive option to control existed HPV infection and related lesions. The two early viral oncoproteins, E6 and E7, are continuously expressed in most HPV-related pre- and cancerous cells, and are
Yan Zhou   +3 more
doaj   +1 more source

Class A CpG oligodeoxynucleotide inhibits IFN-γ-induced signaling and apoptosis in lung cancer. [PDF]

open access: yesThorac Cancer, 2020
Teranishi S   +9 more
europepmc   +1 more source

In Vivo Role of p38 Mitogen-Activated Protein Kinase in Mediating the Anti-inflammatory Effects of CpG Oligodeoxynucleotide in Murine Asthma [PDF]

open access: bronze, 2002
Barun K. Choudhury   +7 more
openalex   +1 more source

Home - About - Disclaimer - Privacy